AstraZeneca in Ireland
AstraZeneca carries on business in Ireland under the name of AstraZeneca Pharmaceuticals (Ireland) Ltd. At present its marketing and administration functions are centred in College Park House, 20 Nassau Street, Dublin 2.
Currently over 100 people are employed by AstraZeneca Pharmaceuticals (Ireland) Ltd., with over half this number directly involved in promotion of the company's products to healthcare professionals throughout the country. AstraZeneca is ranked as one of the worlds leading pharmaceutical companies.
AstraZeneca's products are mainly from seven therapy areas with portfolios including many world leaders and a range of high potential therapies for treating cancer (Casodex™, Arimidex™ and Faslodex™), Gastrointestinal disease (Nexium™), Asthma (Symbicort™), Cholestrol (Crestor™), Schizophrenia (Seroquel™).
AstraZeneca worldwide spends over $12 million everyday on research and development.
AstraZeneca aims to use its leading positions in many important areas of healthcare to make a difference to the lives of patients and the healthcare providers who treat them.
We are committed to continued innovation, close customer relationships, people development and a responsible approach to business.
If you would like more information on AstraZeneca Pharmaceuticals (Ireland) Ltd please contact us or phone 01-6097100.
Page tools
Share price
- London
-
33.40 GBP - New York
-
51.24 USD - Stockholm
-
371.20 SEK
At Sep 6, 2010 7:54 PM GMT
